Ilex Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Non-Voting
MKC
|
+$213M |
| 2 |
Flutter Entertainment
FLUT
|
+$198M |
| 3 |
Colgate-Palmolive
CL
|
+$164M |
| 4 |
Boston Scientific
BSX
|
+$157M |
| 5 |
McDonald's
MCD
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$184M |
| 2 |
Procter & Gamble
PG
|
+$180M |
| 3 |
Linde
LIN
|
+$149M |
| 4 |
RPM International
RPM
|
+$122M |
| 5 |
Darling Ingredients
DAR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 35.16% |
| 2 | Healthcare | 24.45% |
| 3 | Consumer Discretionary | 20.47% |
| 4 | Technology | 5.32% |
| 5 | Industrials | 5.31% |
Similar funds
Ilex Capital Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Ilex Capital Partners held 174 positions worth $3.54B, up 13% from $3.13B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Ilex Capital Partners deployed $455M of net new capital in Q4 2025, opening 39 new positions and adding to 21 existing holdings. Its largest new stake was McCormick & Company Non-Voting: 3,201,107 shares worth $218M.
By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was T-Mobile US, an estimated $71.3M trimmed.
- Ilex Capital Partners's largest Q4 2025 buy was McCormick & Company Non-Voting: 3,201,107 shares worth $218M.
- Ilex Capital Partners added most to Flutter Entertainment in Q4 2025, an estimated $198M increase.
- Ilex Capital Partners's biggest Q4 2025 reduction was T-Mobile US, cutting an estimated $71.3M.
- Ilex Capital Partners fully exited Ferrari in Q4 2025, selling an estimated $184M.
- Ilex Capital Partners's ten largest holdings make up 46% of its $3.54B portfolio in Q4 2025.
- Ilex Capital Partners opened 39 new positions and closed 108 in Q4 2025.
- Ilex Capital Partners's portfolio value rose 13% quarter-over-quarter to $3.54B.
Based on Ilex Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.